Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AIM ImmunoTech Inc. Common Stock (NY:AIM)

2.700 +0.010 (+0.37%)
Official Closing Price Updated: 8:00 PM EDT, Aug 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AIM ImmunoTech Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views
 
Via Benzinga
Topics Earnings
Top movers analysis in the middle of the day on 2025-07-29: top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Earnings Preview For AIM ImmunoTech
 
Via Benzinga
Insights into AIM ImmunoTech's Upcoming Earnings
 
Via Benzinga
Exploring AIM ImmunoTech's Earnings Expectations
 
Via Benzinga
AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For August 14, 2025
 
Via Benzinga
Uncovering Potential: AIM ImmunoTech's Earnings Preview
 
Via Benzinga
What's going on in today's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
The trading volume of these stocks is deviating from the norm in today's session.
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
Preview: AIM ImmunoTech's Earnings
 
Via Benzinga
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Crude Oil Gains 2%; CEA Industries Shares Spike Higher
 
Via Benzinga
Why Is Micro-Cap AIM ImmunoTech Stock Surging?
AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer patients. 
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
US Stocks Mixed; Enterprise Products Partners Posts Upbeat Earnings
 
Via Benzinga
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March
 
Via Benzinga
Topics Economy Stocks
Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Earnings Scheduled For March 28, 2025
 
Via Benzinga
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025. 
Via Stocktwits
Earnings Scheduled For November 15, 2024
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024
AIM stock results show that AIM ImmunoTech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023
AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For April 2, 2024
Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.